Table 2 Prevalence of HPV types among cases of SCCC and dysplasia and among controls
From: Human papillomavirus infection and squamous cell carcinoma of the conjunctiva
SCCC ( n =94) | Dysplasia ( n =39) | Controls ( n =285) | |||||||
|---|---|---|---|---|---|---|---|---|---|
HPV type | Single a | Multiple a | Total (%) | Single a | Multiple a | Total (%) | Single a | Multiple a | Total (%) |
Mucosal | |||||||||
None | 88 (93.6) | 36 (92.3) | 275 (96.5) | ||||||
Any | 6 | 6 (6.4) | 3 | 3 (7.7) | 8 (1) | 2 | 10 (3.5) | ||
16 | 1 | 1 | 2 (0.7) | ||||||
45 | 1 | 1 (1.1) | |||||||
52 | 2 | 2 (0.7) | |||||||
53 | 2 | 2 (0.7) | |||||||
83 | 1 | 1 (2.5) | |||||||
Uncharacterised | 5 | 5 (5.3) | 2 | 2 (5.1) | 7 (1) | 7 (2.5) | |||
Cutaneous | |||||||||
None | 52 (55.3) | 23 (59.0) | 255 (89.5) | ||||||
Any | 18 (1) | 24 (1) | 42 (44.7) | 4 | 12 (1) | 16 (41.0) | 26 (11) | 4 | 30 (10.5) |
5 | 2 | 13 | 15 (16.0) | 8 | 8 (20.5) | 5 (2) | 2 | 7 (2.5) | |
8 | 5 | 11 (1) | 16 (17.0) | 2 | 2 (5.1) | 1 | 1 (0.4) | ||
9 | 1 | 1 (1.1) | 1 (1) | 1 (2.6) | 1 (1) | 1 (0.4) | |||
12 | 4 | 4 (4.3) | 1 | 1 (0.4) | |||||
14 | 1 | 7 | 8 (8.5) | 6 | 6 (15.4) | 3 | 3 (1.1) | ||
15 | 1 | 1 (2.6) | 6 (3) | 1 | 7 (2.5) | ||||
17 | 1 | 3 | 4 (4.3) | 1 | 4 | 5 (12.8) | |||
19 | 1 | 1 (1.1) | 2 | 2 (5.1) | |||||
20 | 4 | 4 (4.3) | 1 | 1 (2.6) | 1 | 1 (0.4) | |||
21 | 1 (1) | 3 | 4 (4.3) | 1 | 1 (0.4) | ||||
22 | 1 | 1 | 2 (2.1) | 2 (1) | 2 (5.1) | 2 (1) | 2 | 4 (1.4) | |
23 | 6 | 6 (6.4) | 2 | 2 (5.1) | 1 | 1 (0.4) | |||
24 | 3 | 6 | 9 (9.6) | 1 | 1 | 2 (5.1) | 4 (1) | 2 | 6 (2.1) |
25 | 1 | 1 (1.1) | 1 | 1 (2.6) | |||||
36 | 1 | 1 (1.1) | |||||||
37 | 2 | 2 (2.1) | 1 | 1 (2.6) | |||||
38 | 1 | 3 | 4 (4.3) | ||||||
49 | 2 | 2 (2.1) | |||||||
75 | 2 (1) | 2 (2.1) | |||||||
76 | 1 | 1 (1.1) | 1 | 1 (2.6) | 2 (2) | 2 (0.7) | |||
80 | 1 | 1 (1.1) | 1 | 1 (2.6) | |||||
92 | 1 | 1 (1.1) | |||||||
93 | 1 | 1 (1.1) | |||||||
96 | 1 | 1 (1.1) | 1 (1) | 1 (2.6) | |||||
Uncharacterised | 1 | 1 (1.1) | 4 (1) | 4 (1.4) | |||||
